Yusuke Doi

978 total citations
37 papers, 797 citations indexed

About

Yusuke Doi is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Yusuke Doi has authored 37 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Biomaterials and 10 papers in Biomedical Engineering. Recurrent topics in Yusuke Doi's work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (9 papers) and Forensic and Genetic Research (8 papers). Yusuke Doi is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (9 papers) and Forensic and Genetic Research (8 papers). Yusuke Doi collaborates with scholars based in Japan, Egypt and Saudi Arabia. Yusuke Doi's co-authors include Tatsuhiro Ishida, Hiroshi Kiwada, Amr S. Abu Lila, Takuya Suzuki, Yuji Yamamoto, Satoru Miyaishi, Kazuya Nakamura, Hideo Ishizu, Masanori Osawa and Naoyuki Uchida and has published in prestigious journals such as Nucleic Acids Research, Genes & Development and Biochemical and Biophysical Research Communications.

In The Last Decade

Yusuke Doi

37 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Doi Japan 16 535 282 195 121 117 37 797
Euan Ramsay Canada 15 543 1.0× 262 0.9× 162 0.8× 110 0.9× 59 0.5× 25 772
Ladan Parhamifar Denmark 20 612 1.1× 221 0.8× 206 1.1× 140 1.2× 128 1.1× 31 1.0k
Junxiao Ye China 17 516 1.0× 229 0.8× 176 0.9× 78 0.6× 58 0.5× 23 864
Reiner Zeisig Germany 17 396 0.7× 203 0.7× 80 0.4× 128 1.1× 31 0.3× 44 704
Zhenjia Wang United States 12 591 1.1× 142 0.5× 110 0.6× 60 0.5× 53 0.5× 26 848
Patrick J. Kennedy Portugal 15 361 0.7× 147 0.5× 125 0.6× 94 0.8× 41 0.4× 21 706
Hari Krishna Sajja United States 8 342 0.6× 297 1.1× 279 1.4× 91 0.8× 66 0.6× 10 727
Suleixin Yang China 12 430 0.8× 151 0.5× 253 1.3× 63 0.5× 96 0.8× 20 776
Sebastian C.J. Steiniger United States 11 460 0.9× 258 0.9× 173 0.9× 152 1.3× 34 0.3× 12 804
Pierre‐Alain Burnouf Taiwan 12 456 0.9× 221 0.8× 173 0.9× 69 0.6× 19 0.2× 15 738

Countries citing papers authored by Yusuke Doi

Since Specialization
Citations

This map shows the geographic impact of Yusuke Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Doi more than expected).

Fields of papers citing papers by Yusuke Doi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Doi. The network helps show where Yusuke Doi may publish in the future.

Co-authorship network of co-authors of Yusuke Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Doi. A scholar is included among the top collaborators of Yusuke Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Doi. Yusuke Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doi, Yusuke, Taro Shimizu, Hidenori Ando, et al.. (2021). Liposomalization of Oxaliplatin Exacerbates the Non-Liposomal Formulation-Induced Decrease of Sweet Taste Sensitivity in Rats. Journal of Pharmaceutical Sciences. 110(12). 3937–3945. 3 indexed citations
2.
Shimizu, Taro, Amr S. Abu Lila, Yusuke Doi, et al.. (2017). Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model. Cancer Science. 108(9). 1864–1869. 21 indexed citations
3.
Doi, Yusuke, et al.. (2015). Identification and evaluation of potential forensic marker proteins in vaginal fluid by liquid chromatography/mass spectrometry. Analytical and Bioanalytical Chemistry. 407(23). 7135–7144. 21 indexed citations
4.
Nakamura, Hiroyuki, et al.. (2013). Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome. European Journal of Pharmaceutics and Biopharmaceutics. 87(1). 142–151. 21 indexed citations
5.
Lila, Amr S. Abu, et al.. (2012). Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin. European Journal of Pharmaceutics and Biopharmaceutics. 81(3). 524–531. 14 indexed citations
6.
Lila, Amr S. Abu, Tomoko Okada, Yusuke Doi, et al.. (2012). Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: Synergy or antagonism?. International Journal of Pharmaceutics. 426(1-2). 263–270. 8 indexed citations
7.
8.
Ohtsuki, Takashi, Hidetaka Yamamoto, Yusuke Doi, & Masahiko Sisido. (2010). Use of EF-Tu mutants for determining and improving aminoacylation efficiency and for purifying aminoacyl tRNAs with non-natural amino acids. The Journal of Biochemistry. 148(2). 239–246. 21 indexed citations
9.
10.
Lila, Amr S. Abu, Yusuke Doi, Kazuya Nakamura, Tatsuhiro Ishida, & Hiroshi Kiwada. (2009). Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor. Journal of Controlled Release. 142(2). 167–173. 46 indexed citations
11.
Funakoshi, Yuji, Yusuke Doi, Nao Hosoda, et al.. (2007). Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases. Genes & Development. 21(23). 3135–3148. 146 indexed citations
12.
13.
Kofuji, Satoshi, Takeshi Sakuno, Shinya Takahashi, et al.. (2006). The decapping enzyme Dcp1 participates in translation termination through its interaction with the release factor eRF3 in budding yeast. Biochemical and Biophysical Research Communications. 344(2). 547–553. 4 indexed citations
14.
Doi, Yusuke, Kenichi Hitomi, John A. Tainer, & Shigenori Iwai. (2005). Synthesis of oligonucleotides containing 2′-fluorinated thymidine glycol as mechanism-based inhibitors of endonuclease III. Nucleic Acids Symposium Series. 49(1). 195–196. 1 indexed citations
15.
16.
Yamamoto, Yuji, Yusuke Doi, T. Takata, et al.. (2004). A new 39-plex analysis method for SNPs including 15 blood group loci. Forensic Science International. 144(1). 45–57. 54 indexed citations
17.
Yamamoto, Yuji, et al.. (2002). Evaluation of a method for typing the microsatellite D12S391 locus using a new primer pair and capillary electrophoresis.. Okayama University Scientific Achievement Repository (Okayama University). 56(5). 229–36. 6 indexed citations
18.
Doi, Yusuke, et al.. (2002). . 7(1). 61–69. 1 indexed citations
19.
Yamamoto, Yuji, et al.. (1999). Polymorphism of the D12S391 microsatellite in a Japanese population sample. Forensic Science International. 102(1). 61–66. 3 indexed citations
20.
Suzuki, Yukio, et al.. (1996). Preparation of Two Pyridoxine-α-Glucosides by α-Glucosidase from Mucor javanicus. Journal of Applied Glycoscience. 43(3). 369–372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Euan Ramsay Breakdown of academic impact, for papers by Ladan Parhamifar Breakdown of academic impact, for papers by Junxiao Ye Breakdown of academic impact, for papers by Reiner Zeisig Breakdown of academic impact, for papers by Zhenjia Wang Breakdown of academic impact, for papers by Patrick J. Kennedy Breakdown of academic impact, for papers by Hari Krishna Sajja Breakdown of academic impact, for papers by Suleixin Yang Breakdown of academic impact, for papers by Sebastian C.J. Steiniger Breakdown of academic impact, for papers by Pierre‐Alain Burnouf
Rankless by CCL
2026